Department of Neurosurgery, David Geffen School of Medicine at UCLA, Box 957039, Los Angeles, CA 90095-7039, USA.
J Neurotrauma. 2012 May 1;29(7):1469-82. doi: 10.1089/neu.2011.2161. Epub 2012 Mar 29.
We have previously presented evidence that the development of secondary traumatic axonal injury is related to the degree of local cerebral blood flow (LCBF) and flow-metabolism uncoupling. We have now tested the hypothesis that augmenting LCBF in the acute stages after brain injury prevents further axonal injury. Data were acquired from rats with or without acetazolamide (ACZ) that was administered immediately following controlled cortical impact injury to increase cortical LCBF. Local cerebral metabolic rate for glucose (LCMRglc) and LCBF measurements were obtained 3 h post-trauma in the same rat via ¹⁸F-fluorodeoxyglucose and ¹⁴C-iodoantipyrine co-registered autoradiographic images, and compared to the density of damaged axonal profiles in adjacent sections, and in additional groups at 24 h used to assess different populations of injured axons stereologically. ACZ treatment significantly and globally elevated LCBF twofold above untreated-injured rats at 3 h (p<0.05), but did not significantly affect LCMRglc. As a result, ipsilateral LCMRglc:LCBF ratios were reduced by twofold to sham-control levels, and the density of β-APP-stained axons at 24 h was significantly reduced in most brain regions compared to the untreated-injured group (p<0.01). Furthermore, early LCBF augmentation prevented the injury-associated increase in the number of stained axons from 3-24 h. Additional robust stereological analysis of impaired axonal transport and neurofilament compaction in the corpus callosum and cingulum underlying the injury core confirmed the amelioration of β-APP axon density, and showed a trend, but no significant effect, on RMO14-positive axons. These data underline the importance of maintaining flow-metabolism coupling immediately after injury in order to prevent further axonal injury, in at least one population of injured axons.
我们之前已经提出证据表明,继发性创伤性轴索损伤的发展与局部脑血流(LCBF)和血流代谢解耦的程度有关。我们现在已经测试了这样一个假设,即在脑损伤后的急性期增加 LCBF 可以防止进一步的轴索损伤。数据来自于接受或不接受乙酰唑胺(ACZ)治疗的大鼠,ACZ 在皮质撞击伤后立即给予以增加皮质 LCBF。在同一大鼠中,通过¹⁸F-氟脱氧葡萄糖和¹⁴C-碘安替比林共注册放射性自显影图像,在创伤后 3 小时获得局部脑葡萄糖代谢率(LCMRglc)和 LCBF 测量值,并与相邻切片中受损轴突形态的密度进行比较,以及在 24 小时的其他组中,使用立体学评估不同损伤轴突群体。ACZ 治疗可使 3 小时时未治疗的受伤大鼠的 LCBF 显著增加两倍(p<0.05),但对 LCMRglc 没有显著影响。结果,同侧 LCMRglc:LCBF 比值降低至与假手术对照组相同的水平,与未治疗的受伤组相比,24 小时时大多数脑区的 β-APP 染色轴突密度显著降低(p<0.01)。此外,早期 LCBF 增加可防止损伤后 3-24 小时内染色轴突数量的增加。对损伤核心下胼胝体和扣带回中受损轴突运输和神经丝紧缩的额外稳健立体学分析证实了β-APP 轴突密度的改善,并显示了 RMO14 阳性轴突的趋势,但无显著影响。这些数据强调了在损伤后立即维持血流代谢耦联的重要性,以防止至少一种损伤轴突的进一步损伤。